GT BIOPHARMA, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
GT BIOPHARMA, INC. (GTBP) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $537.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2021-12-29
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-09-30 was $1.15M, a 3.99% increase year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was -$830.00K.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was $219.00K, a 72.07% decline year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-12-31 was -$2.00M, a 197.56% decline year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was -$838.00K, a 126.57% decline from fiscal 2019.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $3.15M, a 2219.12% increase from fiscal 2018.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $136.00K, a 90.37% decline from fiscal 2017.
- GT BIOPHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $1.41M, a 49.80% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | $1.15M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | $318.00K derived: sum of 2 quarters · filed 2021-12-29 | $537.00K 10-Q · filed 2021-11-10 | -$1.47M derived: sum of 4 quarters · filed 2021-12-29 | |||
| 2021-06-30 | -$830.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-12-29 | -$611.00K 10-Q/A · filed 2021-12-29 | -$2.61M derived: sum of 3 quarters · filed 2021-12-29 | -$1.51M derived: sum of 4 quarters · filed 2021-12-29 | |||
| 2021-03-31 | $219.00K 10-Q · filed 2021-05-17 | -$1.78M derived: sum of 2 quarters · filed 2021-05-17 | -$680.00K derived: sum of 3 quarters · filed 2021-11-10 | -$1.40M derived: sum of 4 quarters · filed 2021-12-29 | |||
| 2020-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | -$899.00K derived: sum of 2 quarters · filed 2021-11-10 | -$1.62M derived: sum of 3 quarters · filed 2021-12-29 | -$838.00K 10-K · filed 2021-04-16 | |||
| 2020-09-30 | $1.10M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | $381.00K derived: sum of 2 quarters · filed 2021-12-29 | $1.17M 10-Q · filed 2021-11-10 | $1.36M 10-Q · filed 2020-11-13 | $3.22M derived: sum of 4 quarters · filed 2021-12-29 | ||
| 2020-06-30 | -$723.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-12-29 | $61.00K 10-Q/A · filed 2021-12-29 | $261.00K 10-Q · filed 2020-08-14 | $2.11M derived: sum of 3 quarters · filed 2021-12-29 | $3.19M derived: sum of 4 quarters · filed 2021-12-29 | ||
| 2020-03-31 | $784.00K 10-Q · filed 2021-05-17 | $1.42M 10-Q · filed 2020-05-15 | $2.84M derived: sum of 2 quarters · filed 2021-05-17 | $3.91M derived: sum of 3 quarters · filed 2021-05-17 | $3.12M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $3.13M derived: sum of 2 quarters · filed 2021-04-16 | $2.34M derived: sum of 3 quarters · filed 2021-04-16 | $3.15M 10-K · filed 2021-04-16 | |||
| 2019-09-30 | $1.07M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-13 | $284.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.10M 10-Q · filed 2020-11-13 | $1.29M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | -$791.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-18 | $26.00K 10-Q/A · filed 2020-08-18 | $215.00K derived: sum of 3 quarters · filed 2020-08-18 | $743.00K derived: sum of 4 quarters · filed 2020-08-18 | |||
| 2019-03-31 | $817.00K 10-Q · filed 2020-05-15 | $1.01M derived: sum of 2 quarters · filed 2020-05-15 | $1.53M derived: sum of 3 quarters · filed 2020-05-15 | $1.49M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $717.00K derived: sum of 2 quarters · filed 2020-03-27 | $670.00K derived: sum of 3 quarters · filed 2020-03-27 | $136.00K 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $481.00K derived: sum of 2 quarters · filed 2019-11-14 | -$53.00K 10-Q · filed 2019-11-14 | -$521.00K derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$581.00K 10-Q · filed 2019-08-14 | -$1.05M derived: sum of 3 quarters · filed 2019-08-14 | -$451.00K derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$534.00K 10-Q · filed 2019-05-15 | -$1.00M derived: sum of 2 quarters · filed 2019-05-15 | -$404.00K derived: sum of 3 quarters · filed 2019-05-15 | $355.00K derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $130.00K derived: sum of 2 quarters · filed 2019-03-29 | $889.00K derived: sum of 3 quarters · filed 2019-03-29 | $1.41M 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $598.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.36M derived: sum of 2 quarters · filed 2018-11-14 | $1.88M 10-Q · filed 2018-11-14 | $2.29M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.28M 10-Q · filed 2018-08-14 | $1.69M derived: sum of 3 quarters · filed 2018-08-14 | $2.59M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $523.00K 10-Q · filed 2018-05-15 | $933.00K derived: sum of 2 quarters · filed 2018-05-15 | $1.83M derived: sum of 3 quarters · filed 2018-05-15 | $2.36M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $410.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $1.30M derived: sum of 2 quarters · filed 2018-03-01 | $1.84M derived: sum of 3 quarters · filed 2018-03-01 | $2.81M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $895.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $1.43M derived: sum of 2 quarters · filed 2018-02-28 | $2.40M 10-Q/A · filed 2018-02-28 | $2.26M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $532.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $1.51M 10-Q/A · filed 2018-02-28 | $1.36M derived: sum of 3 quarters · filed 2018-02-28 | $2.12M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $976.00K 10-Q/A · filed 2018-02-28 | $833.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.59M derived: sum of 3 quarters · filed 2018-02-28 | $1.86M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | -$143.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $610.00K derived: sum of 2 quarters · filed 2018-02-28 | $886.00K derived: sum of 3 quarters · filed 2018-02-28 | $880.00K 10-K/A · filed 2018-02-28 | |||
| 2015-09-30 | $753.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $1.03M derived: sum of 2 quarters · filed 2018-02-28 | $1.02M 10-Q/A · filed 2018-02-28 | $416.00K derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-06-30 | $276.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $270.00K 10-Q/A · filed 2018-02-28 | -$337.00K derived: sum of 3 quarters · filed 2018-02-28 | -$185.00K derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-03-31 | -$6.00K 10-Q/A · filed 2018-02-28 | -$613.00K derived: sum of 2 quarters · filed 2018-02-28 | -$461.00K derived: sum of 3 quarters · filed 2018-02-28 | -$366.00K derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2014-12-31 | -$607.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | -$455.00K derived: sum of 2 quarters · filed 2018-02-28 | -$360.00K derived: sum of 3 quarters · filed 2018-02-28 | -$276.00K 10-K/A · filed 2018-02-28 | |||
| 2014-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $247.00K derived: sum of 2 quarters · filed 2015-11-13 | $331.00K 10-Q · filed 2015-11-13 | $366.00K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $179.00K 10-Q · filed 2015-08-14 | $214.00K derived: sum of 3 quarters · filed 2015-08-14 | $375.00K derived: sum of 4 quarters · filed 2015-08-14 | |||
| 2014-03-31 | $84.00K 10-Q · filed 2015-05-14 | $119.00K derived: sum of 2 quarters · filed 2015-05-14 | $280.00K derived: sum of 3 quarters · filed 2015-05-14 | $403.00K derived: sum of 4 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $196.00K derived: sum of 2 quarters · filed 2015-03-31 | $319.00K derived: sum of 3 quarters · filed 2015-03-31 | $480.00K 10-K · filed 2015-03-31 | |||
| 2013-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08 | $284.00K derived: sum of 2 quarters · filed 2015-01-08 | $445.00K 10-Q · filed 2015-01-08 | -$700.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2013-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | $284.00K 10-Q · filed 2015-01-08 | -$861.00K derived: sum of 3 quarters · filed 2015-01-08 | -$892.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2013-03-31 | $161.00K 10-Q · filed 2015-01-08 | -$984.00K derived: sum of 2 quarters · filed 2015-01-08 | -$1.01M derived: sum of 3 quarters · filed 2015-01-08 | $651.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2012-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | -$1.18M derived: sum of 2 quarters · filed 2015-01-08 | $490.00K derived: sum of 3 quarters · filed 2015-01-08 | $605.00K 10-K · filed 2015-01-08 | |||
| 2012-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-12-17 | $1.64M derived: sum of 2 quarters · filed 2014-12-17 | $1.75M 10-Q · filed 2014-12-17 | $1.62M derived: sum of 4 quarters · filed 2014-12-17 | |||
| 2012-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-12 | $1.78M 10-Q · filed 2014-12-12 | $1.65M derived: sum of 3 quarters · filed 2014-12-12 | $2.07M derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2012-03-31 | $115.00K 10-Q · filed 2014-12-10 | -$19.00K derived: sum of 2 quarters · filed 2014-12-10 | $402.00K derived: sum of 3 quarters · filed 2014-12-10 | -$1.01M derived: sum of 4 quarters · filed 2014-12-10 | |||
| 2011-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $287.00K derived: sum of 2 quarters · filed 2014-11-18 | -$1.13M derived: sum of 3 quarters · filed 2014-11-18 | $533.00K 10-K · filed 2014-11-18 | |||
| 2011-09-30 | $421.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | -$993.00K derived: sum of 2 quarters · filed 2012-11-21 | $667.00K 10-Q · filed 2012-11-21 | $586.00K derived: sum of 4 quarters · filed 2012-11-21 | |||
| 2011-06-30 | -$1.41M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $246.00K 10-Q/A · filed 2012-09-13 | $165.00K derived: sum of 3 quarters · filed 2012-09-13 | $216.00K derived: sum of 4 quarters · filed 2012-09-13 | |||
| 2011-03-31 | $1.66M 10-Q · filed 2012-05-21 | $1.58M derived: sum of 2 quarters · filed 2012-05-21 | $1.63M derived: sum of 3 quarters · filed 2012-05-21 | ||||
| 2010-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$30.00K derived: sum of 2 quarters · filed 2012-04-16 | $154.00K 10-K · filed 2012-04-16 | ||||
| 2010-09-30 | $51.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $235.00K 10-Q · filed 2011-11-21 | |||||
| 2010-06-30 | $184.00K 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |